000 | 01980 a2200541 4500 | ||
---|---|---|---|
005 | 20250516142604.0 | ||
264 | 0 | _c20140109 | |
008 | 201401s 0 0 eng d | ||
022 | _a1476-5551 | ||
024 | 7 |
_a10.1038/leu.2013.89 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCarnevale, J | |
245 | 0 | 0 |
_aSYK regulates mTOR signaling in AML. _h[electronic resource] |
260 |
_bLeukemia _cNov 2013 |
||
300 |
_a2118-28 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aExtracellular Signal-Regulated MAP Kinases _xgenetics |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntracellular Signaling Peptides and Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xgenetics |
650 | 0 | 4 |
_aMitogen-Activated Protein Kinases _xgenetics |
650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xgenetics |
650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xgenetics |
650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
650 | 0 | 4 | _aReal-Time Polymerase Chain Reaction |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 | _aSyk Kinase |
650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xgenetics |
650 | 0 | 4 | _aTumor Cells, Cultured |
700 | 1 | _aRoss, L | |
700 | 1 | _aPuissant, A | |
700 | 1 | _aBanerji, V | |
700 | 1 | _aStone, R M | |
700 | 1 | _aDeAngelo, D J | |
700 | 1 | _aRoss, K N | |
700 | 1 | _aStegmaier, K | |
773 | 0 |
_tLeukemia _gvol. 27 _gno. 11 _gp. 2118-28 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/leu.2013.89 _zAvailable from publisher's website |
999 |
_c22621047 _d22621047 |